Ordinary Shares · CUSIP N52A8C105 · who reports it, how much, and how much it matters to them
42 of the 720 hedge fund managers we track reported shares of Innio N.V. (Nasdaq: INIO) on Form 13F for 30 June 2026. Between them they reported USD 1.2bn. The largest position belongs to POINT72 Asset Management, at USD 178m. The manager with the most riding on it is Dragoneer Investment Group, where it is 4.0% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | POINT72 Asset Management17 funds on PPLI.com | USD 178m | 0.2% |
| 2 | Citadel Advisors32 funds on PPLI.com | USD 150m | 0.0% |
| 3 | Balyasny Asset Management25 funds on PPLI.com | USD 117m | 0.1% |
| 4 | Dragoneer Investment Group3 funds on PPLI.com | USD 113m | 4.0% |
| 5 | Marshall Wace LLP84 funds on PPLI.com | USD 83m | 0.1% |
| 6 | Freestone Grove Partners1 fund on PPLI.com | USD 82m | 0.5% |
| 7 | Holocene Advisors2 funds on PPLI.com | USD 69m | 0.2% |
| 8 | Millennium Management6 funds on PPLI.com | USD 48m | 0.0% |
| 9 | Burkehill Global Management5 funds on PPLI.com | USD 32m | 1.1% |
| 10 | Covalis Capital LLP3 funds on PPLI.com | USD 28m | 1.6% |
| 11 | Junto Capital Management1 fund on PPLI.com | USD 26m | 0.5% |
| 12 | Hudson Bay Capital Management8 funds on PPLI.com | USD 20m | 0.1% |
| 13 | D. E. Shaw & Co.15 funds on PPLI.com | USD 20m | 0.0% |
| 14 | Tudor Investment Corporation10 funds on PPLI.com | USD 20m | 0.0% |
| 15 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 19m | 0.1% |
| 16 | Aventail Capital Group1 fund on PPLI.com | USD 19m | 1.1% |
| 17 | Encompass Capital Advisors3 funds on PPLI.com | USD 18m | 0.6% |
| 18 | Jain Global1 fund on PPLI.com | USD 18m | 0.1% |
| 19 | LMR Partners2 funds on PPLI.com | USD 17m | 0.1% |
| 20 | Hel Ved Capital Management2 funds on PPLI.com | USD 16m | 1.2% |
| 21 | Capstone Investment Advisors25 funds on PPLI.com | USD 16m | 0.0% |
| 22 | Yaupon Capital Management2 funds on PPLI.com | USD 14m | 0.3% |
| 23 | Squarepoint Ops7 funds on PPLI.com | USD 14m | 0.0% |
| 24 | Atreides Management2 funds on PPLI.com | USD 14m | 0.1% |
| 25 | Verition Fund Management3 funds on PPLI.com | USD 9.9m | 0.1% |
| 26 | Weiss Asset Management5 funds on PPLI.com | USD 8.9m | 0.1% |
| 27 | HBK Investments7 funds on PPLI.com | USD 6m | 0.1% |
| 28 | Pinnbrook Capital Management1 fund on PPLI.com | USD 5.7m | 0.6% |
| 29 | CIBC Asset Management69 funds on PPLI.com | USD 4.8m | 0.0% |
| 30 | Moore Capital Management7 funds on PPLI.com | USD 4.2m | 0.1% |
| 31 | Walleye Capital8 funds on PPLI.com | USD 2.9m | 0.0% |
| 32 | Polymer Capital Management (HK)1 fund on PPLI.com | USD 2.8m | 0.1% |
| 33 | Diameter Capital Partners7 funds on PPLI.com | USD 2m | 0.2% |
| 34 | Capricorn Fund Managers8 funds on PPLI.com | USD 1.8m | 0.1% |
| 35 | Lighthouse Investment Partners190 funds on PPLI.com | USD 1.3m | 0.0% |
| 36 | Sona Asset Management (US)1 fund on PPLI.com | USD 1m | 0.0% |
| 37 | Anson Funds Management8 funds on PPLI.com | USD 989,000 | 0.1% |
| 38 | Scientech Research2 funds on PPLI.com | USD 613,000 | 0.5% |
| 39 | Oxford Asset Management LLP2 funds on PPLI.com | USD 434,000 | 0.2% |
| 40 | Boothbay Fund Management2 funds on PPLI.com | USD 323,000 | 0.0% |
| 41 | Wexford Capital8 funds on PPLI.com | USD 279,000 | 0.0% |
| 42 | The Quarry1 fund on PPLI.com | USD 158 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Dragoneer Investment Group | USD 113m | 4.0% |
| 2 | Covalis Capital LLP | USD 28m | 1.6% |
| 3 | Hel Ved Capital Management | USD 16m | 1.2% |
| 4 | Burkehill Global Management | USD 32m | 1.1% |
| 5 | Aventail Capital Group | USD 19m | 1.1% |
| 6 | Encompass Capital Advisors | USD 18m | 0.6% |
| 7 | Pinnbrook Capital Management | USD 5.7m | 0.6% |
| 8 | Freestone Grove Partners | USD 82m | 0.5% |
| 9 | Scientech Research | USD 613,000 | 0.5% |
| 10 | Junto Capital Management | USD 26m | 0.5% |
Innio N.V. trades under the symbol INIO on the Nasdaq. Its CUSIP, the code used on Form 13F, is N52A8C105.
42 of the 720 hedge fund managers PPLI.com tracks reported Innio N.V. shares on Form 13F for 30 June 2026. The largest reported positions were held by POINT72 Asset Management (USD 178m), Citadel Advisors (USD 150m), Balyasny Asset Management (USD 117m), Dragoneer Investment Group (USD 113m) and Marshall Wace LLP (USD 83m).
42 managers in our coverage reported it, and between them they run 617 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Dragoneer Investment Group, where the position was 4.0% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Innio N.V. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.